Caprion Biosciences
2000
FOUNDED
PRIVATE
STATUS
101-200
EMPLOYEES
Buyout/LBO
LATEST DEAL TYPE
5
FINANCING ROUNDS
5
INVESTMENTS
Description
Provider of proteomics and immune monitoring services for the pharmaceutical and biotechnology industry. The company operates two proprietary immune monitoring platforms that offers proprietary multiparametric flow cytometry services for functional analyses of innate and adaptive immune responses and its proteomics business unit, as well as gel-free, label-free mass spectrometry (MS) for comprehensive, quantitative and robust comparative measurement of proteins across large sets of biological samples for the discovery and validation of protein biomarkers.
Website
Formerly Known As
Caprion Proteomics, Caprion Proteomics GP
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
- 141 President Kennedy Avenue
- Suite SB-5658
- Montreal, Quebec H2X 3Y7
- Canada
+1 (514) 000-0000
Caprion Biosciences Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Caprion Biosciences‘s full profile, request access.
Request full access to PitchBookCaprion Biosciences Competitors (12)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AyoxxA Biosystems | Venture Capital-Backed | Cologne, Germany | 00 | 0000 | 000000000000 | 0000 |
| 000000 00000000 | Angel-Backed | Durham, NC | 00 | 000.00 | 0000000000 | 000.00 |
| 0000 000000000 000 | Corporation | Danvers, MA | ||||
| 000000000 | Formerly PE-Backed | Billerica, MA | 000 | 00000 | 00000000 | 00000 |
| 0000000 | Corporation | Austin, TX | 0000 | 000.00 | 00000000 | 000.00 |
Caprion Biosciences Investments (5)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000000 | 31-Jul-2019 | 0000000000 | Laboratory Services (Healthcare) | 000000 0000000 | |
| 0000000000 | 30-Apr-2019 | 0000000000 | Outcome Management (Healthcare) | 000000 0000000 | |
| 0000000 000 | 21-Aug-2018 | 0000000000 | Drug Discovery | 000000 0000000 | |
| 000000 0000000000 | 13-Sep-2016 | 0000000000 | Buildings and Property | 000000 0000000 | |
| National Immune Monitoring Laboratory (Certain Assets) | 01-Jan-2011 | Buyout/LBO | Biotechnology |
Caprion Biosciences Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Primity Bio | Drug Discovery | Fremont, CA | 2010 |
| 0000000000 | Outcome Management (Healthcare) | Carlsbad, CA | 0000 |
Caprion Biosciences Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Caprion Biosciences‘s full profile, request access.
Request full access to PitchBookCaprion Biosciences Executive Team (9)
4 Former Executives
You’re viewing 5 of 9 executives. Get the full list »